Bayer Corporation FDA Approves
Selected Abstract
Bayer Corporation: FDA Approves Once-Daily Cipro(R) XR For The Treatment Of Uncomplicated Urinary Tract Infections (UTIs).
WEST HAVEN, CONNECTICUT, Dec 15, 2002 (CCNMatthews via COMTEX) Uncomplicated UTIs Result In More Than 8 Million Doctor Visits Annually; Extended Release Formulation Provides Once-A-Day Dosing For Patients Bayer Corporation announced today that the U.S. Food and Drug Administration (FDA) has ... December 15, 2002; Canadian Corporate News
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Bayer Corporation: FDA Approves Once-Daily Cipro(R) XR For The Treatment Of Uncomplicated Urinary Tract Infections (UTIs).
|
